Try our new research platform with insights from 80,000+ expert users

DX SaaS vs ITRS Geneos comparison

 

Comparison Buyer's Guide

Executive SummaryUpdated on Jul 24, 2024

Review summaries and opinions

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Categories and Ranking

DX SaaS
Ranking in Application Performance Monitoring (APM) and Observability
65th
Average Rating
6.6
Reviews Sentiment
6.7
Number of Reviews
3
Ranking in other categories
Digital Experience Monitoring (DEM) (17th)
ITRS Geneos
Ranking in Application Performance Monitoring (APM) and Observability
33rd
Average Rating
8.2
Reviews Sentiment
7.1
Number of Reviews
57
Ranking in other categories
Network Monitoring Software (68th), IT Infrastructure Monitoring (45th)
 

Mindshare comparison

As of January 2026, in the Application Performance Monitoring (APM) and Observability category, the mindshare of DX SaaS is 0.6%, up from 0.1% compared to the previous year. The mindshare of ITRS Geneos is 1.1%, down from 1.3% compared to the previous year. It is calculated based on PeerSpot user engagement data.
Application Performance Monitoring (APM) and Observability Market Share Distribution
ProductMarket Share (%)
ITRS Geneos1.1%
DX SaaS0.6%
Other98.3%
Application Performance Monitoring (APM) and Observability
 

Featured Reviews

JM
Technical Manager at Tech Mahindra Limited
It's highly customizable but lacks many features of available in competing solutions
DX SaaS is a latecomer to the APM market. Some things that are straightforward in Dynatrace are complicated in DX. For example, upgrading the agents is a seamless process in Dynatrace, but it's a pain in DX SaaS. You should be able to upgrade in the Application Command Center. However, it is not working correctly. They upgrade the product every 15 to 30 days, and the process isn't seamless. It's like implementing the solution all over again. We monitor around 1,000-plus applications and have more than 100,000 agents, so we require a smooth upgrade process. It's nearly impossible to stay updated on the latest version. Upgrading the Dynatrace agent is smoother. You don't need to worry about it. If the agent is on the Dynatrace server, you only need to push it. After that, you will be notified to reboot the APM or CLM. That's it. It took us three years to deploy the agent on 1,000-plus applications across 40,000-plus servers. Now, they are saying they are ending support for 7.0.49, and we need to upgrade. The path to upgrading isn't straightforward. The first process is manual, and we can push it to different servers so it is visible. What's our configuration? Who is going to do the configuration? It's not typical or practical. I don't understand how product teams don't see that. That feature is not there. We hope they add this feature to the new product called DX Platform, which consists of net apps. All those network monitoring tools will be combined into DX Platform. All the monitoring functionality is moved to DX Platform. You can't see a trend of your metrics grouped according to the last month, six months, one year, etc. The resolution is not there. I want granular visibility into data captured in the last 15 seconds. Those are essential features. I am not saying that DX lacks solid features, but they need to consider it. Some core functionality of the product is missing. We have around 50-plus requests to add previously available features in the on-premise version. That is one reason application teams are reluctant to go to DX SaaS. We are struggling to make them understand and trying to find alternatives for the existing features. We've had many discussions with the product team, telling them we need this functionality. However, they tell us it's not on their product roadmap. They are gradually adding other features, but we need our requirements to be a priority. You cannot say you will try to add those requested features that aren't on your product roadmap. There is always a catch in the product. We use around 10 tenants in production and six in the test run. First of all, there is nothing in the pane. If we are trying to see the data from an application, how do we know which tenant and application are reporting? There was a feature called Enterprise Team Center, but that functionality has been removed. All the applications are connected to the manager, which is connected to ETC. If you go to ETC, you can find the server and see your data, but that functionality was not there. Every product should have a management feature, but that is missing, and they are saying that it is not there in the roadmap. It is a basic requirement. You need to understand that. That is not there, manager, and they are saying that is not there in the roadmap as well. They have created a new tenant page temporarily. It is not there currently. It is not a required thing. There is a feature called Domain, but that concept is gone. We've struggled a lot, and what they provided in the initial migration stage is no longer working. We were delayed for two months because we didn't give them the correct input. They don't know their product. We tell them there is a problem, and they say they're fixing it. Are we their Guinea pig? You cannot treat your customers like this.
Durai CT - PeerSpot reviewer
Head FM Monitoring at a financial services firm with 10,001+ employees
A stable, scalable, and flexible monitoring tool
Real-time data is one of the unique features that ITRS Geneos offers. For example, if there is an impact on a particular server and a particular application, I want to see what the impact is or what the CPU or hardware usage information is, as well as the service in the same application. I can see the real-time data and the impact by accessing ITRS Geneos and looking at the tree. I don't want a tool that tells me when something is broken. I want the tool to tell me when something is going to break. That is the difference between ITRS Geneos and other tools. I want proactive monitoring, not reactive. I don't need to be notified after the fact that something has broken. If something is broken, I get a notification by email, and some of my customers are going to call me. ITRS Geneos provides proactive monitoring. The great advantage of this tool is real-time monitoring. ITRS Geneos not only alerts us but also gives us a real-time view of the data. This is the tool's first great advantage. It is also lightweight and flexible and can adapt to monitor even low-latency systems, which is the tool's second advantage. Another great feature of this tool is its good presentation layer, which allows us to build custom dashboards to present to business stakeholders. This gives them a high-level status of what is being monitored. If we compare ITRS Geneos to other tools, we will find that each one specializes in a specific area, but the ITRS Geneos tool is more comprehensive. This is its great advantage.

Quotes from Members

We asked business professionals to review the solutions they use. Here are some excerpts of what they said:
 

Pros

"It supports numerous platforms."
"Actionable insight is the most valuable feature."
"DX allows you to customize and gives you a high degree of control."
"I always appreciate Geneos's stability and ease of use."
"The remarkable feature of Geneos is the dashboard. Geneos' flexible dashboard sets it apart from other monitoring tools. Other solutions have limitations in their dashboard design and can't be customized as much. The Geneos dashboard allows unlimited creativity."
"It's a very powerful application monitoring tool across the industry. Many free, open-source tools are available. There are also paid tools, but ITRS Geneos is a real-time application monitoring tool where the user can monitor, self-configure, and manage alerts through their console."
"The Netprobe is so lightweight compared to the agents that most monitoring tools use. It's really superior to the competition. The agent that is used by almost every competitive tool takes a lot more system resources. It's slower and it requires a greater effort and more compromises in terms of security to install on the monitored servers. With Geneos, because it lives outside the code, it is far easier and far less taxing on the monitored systems."
"The flexibility of the product is most valuable. It is highly customizable. If you put your mind to it and think of something you could do, there's a good possibility you can get it integrated within the console, if it's not readily available. The simplicity or ease of customization has been valuable."
"In my experience, being able to monitor our databases is a valuable feature as we can create our own queries and aren't reliant on the in-built ones."
"One of the most valuable features is that it can be configured by non-developers. It doesn't require development expertise to configure it."
"It's also easy to implement. The implementation of Geneos is very easy and interesting. It's not complicated. It's very quick to implement. The installation is very easy. There are many topics about ITRS Geneos that explain more about the features of the function of Geneos."
 

Cons

"The ability to scale presents a challenge as the cost of handling vast amounts of data in the cloud must be taken into account."
"DX SaaS is a latecomer to the APM market. Some things that are straightforward in Dynatrace are complicated in DX. For example, upgrading the agents is a seamless process in Dynatrace, but it's a pain in DX SaaS. You should be able to upgrade in the Application Command Center. However, it is not working correctly."
"Old user interface and dashboards could be improved."
"I would like to see ITRS integrate its setup editor with a SVN to check-in setup XML after major changes."
"There is a part of the rules for monitoring alerts. I want to understand more about how to choose the samples and the requirements for the rules. That is the part that I want to understand better and get better training for."
"The deployment method for upgrading is a bit tricky. It takes a little bit of manual effort. If that could be a bit more automated, it would help us a lot."
"A lightweight version which could host more than 100 gateways, as we can see slowness while loading all our gateways."
"Data visualization – real time and historical – is a weakness."
"We all look at the same things - CPU, disk space, paging stats, service status with RAG status on each. That could be provided straight out, saving significant time."
"I would also like to see suggested guidelines to accomplish a monitoring task. The issue is that ITRS is so flexible that there is more than one way to complete a task, each with benefits and disadvantages."
"Geneos' application monitoring could be improved a lot. Products like AppDynamics and Dynatrace provide the process thread-level monitoring, but Geneos lacks these capabilities."
 

Pricing and Cost Advice

"Our monthly cost for DX SaaS is approximately $5 per user, which I considered affordable."
"You will get the best price if you get a single global deal."
"The pricing is fairly market-related. They have been very lenient because we have been working with them for so long. An example is that we're currently migrating some of our services to AWS, and they've given us a grace period for some of the things to help with the migration and not to grow additional costs while we are migrating, but it's still on par with the market."
"Given our spend and the amount of service we have in it, the pricing is quite reasonable."
"When I first came in, their pricing was very high. ITRS had a high expectation of what their price should be based on perceived value. I think they have been realizing, more recently, that there are other competitors, so their pricing is a lot better. Licensing for on-premise is okay, however I feel there is quite some work to be done for cloud and containers. We're still working with them to try and work out what that pricing should look like."
"The organization is not just purchasing a license for the product, but also managing services and professional services from ITRS. Another factor is if the implementation is going to be in production, non-production, or both."
"I can say it's not that cheap because the licensing is a little bit costly"
"Pricing and licensing is based on the requirements."
"The product is priced quite high. There are pricing options for customers based on the size of the environment and plug-ins used by the monitoring system."
report
Use our free recommendation engine to learn which Application Performance Monitoring (APM) and Observability solutions are best for your needs.
881,114 professionals have used our research since 2012.
 

Top Industries

By visitors reading reviews
Outsourcing Company
17%
Computer Software Company
12%
Financial Services Firm
12%
Legal Firm
8%
Financial Services Firm
70%
Computer Software Company
5%
Construction Company
3%
Outsourcing Company
2%
 

Company Size

By reviewers
Large Enterprise
Midsize Enterprise
Small Business
No data available
By reviewers
Company SizeCount
Small Business6
Midsize Enterprise12
Large Enterprise39
 

Questions from the Community

Ask a question
Earn 20 points
What is your experience regarding pricing and costs for ITRS Geneos?
The pricing is high. Licensing fees might be around 500$ per server monthly.
What needs improvement with ITRS Geneos?
ITRS Geneos is a legacy system. It predicts or provides proactive measures once an issue is resolved. It doesn't offer any predictive capabilities or root cause analysis. They throw a lot of data i...
What is your primary use case for ITRS Geneos?
ITRS offers multiple products, including upgrades for synthetic monitoring and a SaaS platform. Geneos is used for infrastructure monitoring, covering KPIs such as CPU, memory, processes, network l...
 

Also Known As

CA DXI, CA Digital Experience Insights
Geneos
 

Overview

 

Sample Customers

CNN
ITRS Geneos is used by over 170 financial institutions, including JPMorgan, HSBC, RBS, Deutsche Bank and Goldman Sachs. Clients range from investment banks to exchanges and brokers.
Find out what your peers are saying about DX SaaS vs. ITRS Geneos and other solutions. Updated: December 2025.
881,114 professionals have used our research since 2012.